Russian ⇄ English

"При наличии подтверждающих данных необходимо как можно более понятно представить сведения об альтернативномых способеах, улучшающемих применение или приемлемость применения лекарственного препарата" stresses
pharma.	When supportive data are available, information on alternative methods to facilitate administration or acceptability should be given as explicitly as possible; When supportive data are available, information on alternative methods to facilitate administration or acceptability should be given as explicitly as possible (the EU guideline on Summary of Product Characteristics (2009))